China stabilized the market before the major military parade on Thursday. Whatever happens in the market has a growing influence on public perceptions of the government’s economic management. With more than 90 million individuals holding equity accounts, equity investors are now a bigger constituency than the Communist Party.
Category Archives: Market news
We already know the exact date and place of the next Apple event – September 9, 2015 at the Bill Graham Civic Auditorium in San Francisco.
Apple is expected to show off new iPhone models as well as a new Apple TV.
The Chinese Government continues to find ways to restore confidence in the stock market. After the market closed on Wednesday, the central bank injected 140 billion yuan ($21.8 billion) of liquidity into the banking system. And this comes after a revival of some of the heavier handed tactics the Government used earlier in the summer to try to short prices.
We’ve already informed you about the historic Monday plunge earlier this week. You’re probably wondering how it affected some of the world’s richest people? If you indeed are, keep reading.
Not more than a few days after the last news about the US30 (a.k.a. Dow Jones) comes another plunge, this time the US30 industrial average traded about 600 points lower after falling as much as 1,089 points in the open. The last historical plunge was not more than 777 points in September 29, 2008. …and you thought last week was a big news?!
Greece’s Prime Minister has announced his resignation, clearing the way for new elections.
Greece is determined to utter the latest bail out agreement. The Greek people need to deliver a new mandate.
It was a tough day on Wall Street. In fact, for the US500 (also known as S&P 500) and the US30 (a.k.a. Dow Jones) indices, Thursday marked the worst day of 2015.
The US500 has turned in pretty dull performance so far in 2015. It went negative on the year Thursday—but is basically flat—and in the past one-year period, is up about 3 percent.
Not too long ago, in 2013, Samsung agreed to develop and commercialize biosimilars with Merck & Co. Inc. and Biogen Idec Inc.
Now, only two years later, Samsung Bioepis is charged with developing generic versions of biotechnology drugs and will make its first entry into U.S. stock markets with $1 billion listing of its biotechnology affiliate.